Invention Application
- Patent Title: Substituted quinazolinone compounds
- Patent Title (中): 取代喹唑啉酮化合物
-
Application No.: US10850967Application Date: 2004-05-21
-
Publication No.: US20050059662A1Publication Date: 2005-03-17
- Inventor: Rustum Boyce , Natalia Aurrecoechea , Daniel Chu , Aaron Smith , Christopher Conlee , Brian Thompson , Judith Kuntz , David Musso , Kevin Barvian , Stephen Thomson , William Swain , Kien Du , Brian Chauder , Jason Speake , Michael Bishop
- Applicant: Rustum Boyce , Natalia Aurrecoechea , Daniel Chu , Aaron Smith , Christopher Conlee , Brian Thompson , Judith Kuntz , David Musso , Kevin Barvian , Stephen Thomson , William Swain , Kien Du , Brian Chauder , Jason Speake , Michael Bishop
- Assignee: CHIRON CORPORATION,GLAXOSMITHKLINE
- Current Assignee: CHIRON CORPORATION,GLAXOSMITHKLINE
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/519 ; A61K31/525 ; A61K31/53 ; A61P3/04 ; A61P3/10 ; C07D217/24 ; C07D239/91 ; C07D239/95 ; C07D239/96 ; C07D253/08 ; C07D401/04 ; C07D401/06 ; C07D401/12 ; C07D401/14 ; C07D403/04 ; C07D403/06 ; C07D403/12 ; C07D403/14 ; C07D405/12 ; C07D417/04 ; C07D417/14 ; C07D471/04 ; C07D475/02 ; C07D487/02 ; C07D487/04
Abstract:
A variety of small molecule, guanidine-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases when administered to subjects. The compounds have the structure IA, IB, and IC where the values of the variables are defined herein.
Public/Granted literature
- US07625909B2 Substituted quinazolinone compounds Public/Granted day:2009-12-01
Information query
IPC分类:
